Product Details:
| Packaging Size | 3x10 Tablets |
| Pack Type | Box |
| Manufacturer | Johnlee Pharmaceuticals |
| Usage / Application | Type 2 diabetes |
| Composition | Glimepiride And Metformin HCI Tablets |
| Brand | Glimith MF 0.5 SR |
Glimith MF combines two anti-diabetic agents: Glimepiride and Metformin, used to control blood sugar levels in patients with type 2 diabetes mellitus. The sustained-release (SR) form of glimepiride allows a gradual release, providing a steady effect.
Product Details:
| Packaging Size | 10*10 Tablets |
| Pack Type | Box |
| Usage / Application | Type 2 diabetes |
| Brand | Glimith MF 0.5 SR |
| Composition | Glimepiride & Metformin HCI (Sustained Release) Tablets |
Glimith MF 0.5 SR is a combination oral antidiabetic medication used to control blood sugar levels in patients with Type 2 Diabetes Mellitus (T2DM).
Glimepiride is a sulfonylurea that stimulates the pancreas to release insulin.
Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity.
The SR (Sustained Release) form of Metformin allows for gradual absorption, minimizing gastrointestinal side effects and enabling once-daily dosing.
Product Details:
| Packaging Size | 10*10 Tablets |
| Pack Type | Stripe |
| Pack Size | 1*10 Tablets |
| Strength | 500 mg |
| Formulation | Oral Tablets |
| Indication | Type 2 Diabetes Mellitus |
| Dosage Instructions | 1 Tablet Once Daily |
Glimith MF is a combination oral antidiabetic medication used in the management of type 2 diabetes mellitus. It contains two active ingredients:
Metformin Hydrochloride, which helps decrease glucose production in the liver and improves insulin sensitivity in muscle and fat tissues, helping the body use insulin more effectively.
Glimepiride, a sulfonylurea, which stimulates the pancreas to release more insulin, thereby helping lower blood glucose levels.
Product Details:
| Packaging Size | 10*15 Tablets |
| Pack Type | Box |
| Pack Size | 10*15 Tablets |
| Manufacturer | Glimith MF1 PR |
| Usage / Application | Type 2 diabetes |
| Composition | Glimepiride And Metformin Hydrochloride |
Glimith MF1 PR is a combination medication used to manage type 2 diabetes mellitus in adults. Glimepiride, a sulfonylurea, stimulates insulin release from pancreatic beta cells, while Metformin, a biguanide, reduces glucose production in the liver and improves insulin sensitivity. This dual action helps control blood sugar levels. Taken once daily with food to minimize gastrointestinal side effects, it may cause hypoglycemia, nausea, or weight gain. Consult a doctor for proper dosing, especially if you have kidney, liver, or heart conditions. Regular blood sugar monitoring is essential. Avoid excessive alcohol consumption.
Product Details:
| Packaging Size | 10*10 Tablets |
| Pack Type | Box |
| Pack Size | 10*10 Tablets |
| Usage / Application | Type 2 diabetes |
| Brand | 1000 Mg Glimith MF1 SR |
| Composition | Metformin Hydrochloride Prolonged Release And Glimepiride |
| Form | Tablets |
Glimith‑MF1 SR 1000 is a once‑daily fixed‑dose sustained-release combination of:
Glimepiride 1 mg (sulfonylurea) – stimulates insulin secretion
Metformin 1000 mg SR (biguanide) – reduces hepatic glucose production, delays carbohydrate absorption, and improves insulin tolerance
Combined, these help maintain glycemic control in adult patients whose blood sugar isn’t well managed by lifestyle changes, monotherapy, or dual therapy ([turn0search4][turn0search3])
Product Details:
| Strength | 120 mg |
| Pack Size | 3*10 Capsules |
| Pack Type | Box |
| Brand Name | Slim Trim Active |
| Usages | For weight loss and weight management |
| Composition | Orlistat |
| Product Type | Weight Loss Aid |
| Dosage Form | Oral Capsules |
Product Details:
| Strength | 25 mg |
| Form | Tablets |
| Packaging Size | 10x10 Tablets |
| Packaging Type | Box |
| Composition | Empagliflozin |
| Brand | Empaone |
| Usage | Used for type 2 diabetes mellitus |
Product Details:
| Strength | 500 mg |
| Packaging Type | Box |
| Packaging Size | 10*10 Tablets |
| Brand | 500 Mg Ranoflaws |
| Shelf Life | 36 Month |
| Composition | Ranolazine SR |
| Usages | to treat chronic angina (chest pain). |
Ranoflaws is an extended‑release formulation of ranolazine, a cardiovascular agent used to treat chronic stable angina, particularly when conventional therapies are insufficient. It’s often added to medications like beta-blockers, calcium channel blockers, or nitrates to improve symptom control without affecting heart rate or blood pressure .
Product Details:
| Strength | 1000 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Box |
| Brand | 1 Gm Metgem |
| Usage | To Treat Type 2 Diabetes |
| Composition | Metformin Hydrochloride Extended Release Tablets |
Metgem contains Metformin Hydrochloride, an oral antihyperglycemic agent commonly used to treat type 2 diabetes mellitus. This extended-release (ER) formulation allows for slower absorption, providing a prolonged therapeutic effect with fewer gastrointestinal side effects compared to immediate-release metformin.
Product Details:
| Strength | 500 mg |
| Pack Size | 10*10 Tablets |
| Pack Type | Box |
| Brand | Gliford |
| Composition | Glibenclamide And Metformin |
Product Details:
| Dose/Strength | 6 mg/ml |
| Packaging Type | Box |
| Brand | 6 Mg Lirafit |
| Shelf Life | 36 Months |
| Composition | Liraglutide Prefilled |
| Usages | This medicine is given as a shot under the skin of your stomach, thighs, or upper arm |
Lirafit contains Liraglutide, a GLP-1 receptor agonist used for managing type 2 diabetes mellitus and, in some cases, weight management. It helps regulate blood sugar levels and promotes weight loss by mimicking a natural hormone called glucagon-like peptide-1 (GLP-1).
Product Details:
| Strength | 10 mg |
| Pack Size | 10*10 Tablet |
| Pack Type | Box |
| Brand Name | Prasunoid |
| Manufacturer | Johnlee Pharmaceuticals |
| Usages | To Reduce the Risk of Heart Attacks and Strokes |